Atara Biotherapeutics Announces First Quarter 2019 Financial Results and Recent Operational Progress

NEXT STORY
Crown Bioscience Announces San Diego, CA Site Expansion
PREV STORY
Progenics Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®

author_avatar
NASDAQ Market News

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

author_avatar
NASDAQ Market News

University of Colorado Hospital Again Ranked Among Best in Nation and Best in Colorado

AURORA, Colo., July 21, 2015 (GLOBE NEWSWIRE) -- U.S. News and World Report again ...

author_avatar
NASDAQ Market News